PCI versus CABG for multivessel coronary disease in diabetics

Catheterization and Cardiovascular Interventions

Volumn 73, Issue 1, 2009, Pages 50-58

  Tarantini, Guiseppe ^a,c   Ramondo, Angelo ^a   Napodano, Massimo ^a   Favaretto, Enrico ^a   Gardin, Arrianna ^a   Bilato, Claudio ^a   Nesseris, Georghios ^a   Tarzia, Vincenzo ^a   Cademartiri, Filippo ^b   Gerosa, Gino ^a   Iliceto, Sabino ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Diabetes mellitus; Drug eluting stent; Multivessel disease; Revascularization

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; PACLITAXEL; RAPAMYCIN; TICLOPIDINE; TIROFIBAN;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COLLATERAL CIRCULATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; RISK FACTOR; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS; VASCULAR DISEASE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR DISEASES; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DATABASES AS TOPIC; DIABETES MELLITUS, TYPE 2; DISEASE-FREE SURVIVAL; DRUG-ELUTING STENTS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 60749083177     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21757     Document Type: Article

References (25)

1. The BARI investigators. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing PTCA and CABG in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1997; 96:1761-1769.
2. Abizaid A, Costa MA, Centemero M, Abizaid AS, Legrand VM, Limet RV, Schuler G, Mohr FW, Lindeboom W, Sousa AG, Sousa JE, van Hout B, Hugenholtz PG, Unger F, Serruys PW, Arterial Revascularization Study Group. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: Insights from the Arterial Revascularization Therapy Study (ARTS) Trial. Circulation 2001;104:533-538.
3. SoS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial); a randomized controlled trial. Lancet 2002;360:965-970.
4. Rodriguez A, Bernardi V, Navia J, Baldi J, Grinfeld L, Martinez J, Vogel D, Grinfeld R, Delacasa A, Garrido M, Olivieri R, Mele E, Palacios I, O'Neill W. Argentine Randomized Study: Coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and 1-year follow-up results. ERACI II Investigators. J Am Coll Cardiol 2001;37:51-58.
5. Committee to revise the 1991 guidelines for Coronary Artery Bypass Graft Surgery. ACC/AHH guidelines for coronary artery bypass graft Surgery. J Am Coll Cardiol 1999;34:1262-1347.
6. McGuire DK, Anstrom KJ, Peterson ED. Influence of the angioplasty revascularization investigation national heart, lung, and blood institute diabetic clinical alert on practice patterns: Result from the national cardiovascular network database. Circulation 2003;107:1864-1870.
7. Pereira AC, Lopes NH, Soares PR, Krieger JE, de Oliveira SA, Cesar LA, Ramires JA, Hueb W. Clinical judgement and treatment options in stable multivessel coronary artery disease: Results from the one-year follow-up of the MASS II (Medicine, Angioplasty or Surgery Study II). J Am Coll Cardiol 2006;48: 948-953.
8. Detre KM, Guo P, Holubkov R, Califf RM, Sopko G, Bach R, Brooks MM, Bourassa MG, Shemin RJ, Rosen AD, Krone RJ, Frye RL, Feit F. Coronary revascularization in diabetic patients: A comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1999;99:633-640.
9. Scheen AJ, Warzée F, Legrand VM. Drug-eluting stents: Meta-analysis in diabetic patients. Eur Heart J 2004;25:2167-2168.
10. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004;27:S5-S10.
11. Sianos G, Morel M, Kappetein AP, et al. The SYNTAX score: An angiographic tool grading the complexity of coronary artery disease. Eurointervention 2005;2:219-227.
12. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2006;29:S4-S42.
13. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, Hart JC, Herrmann HC, Hillis LD, Hutter AM Jr, Lytle BW, Marlow RA, Nugent WC, Orszulac TA, Antman EM, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Ornato JP, American College of Cardiology; American Heart Association Task Force on Practice Guidelines, American Society for Thoracic Surgery and the Society of Thoracic Surgeons. ACC/AHA 2004 Guidelines update for coronary artery bypass graft surgery. Circulation 2004;110: 1168-1176.
14. Spaulding C, Henry P, Teiger E, Beatt KK, Bramucci E, Carrié D, Slama MS, Merkely B, Erglis A, Margheri M, Varenne O, Cebrian A, Stoll HP, Snead DB, Bode C, TYPHOON Investigators. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006;355:1093-1104.
15. Ben-Yehuda O. Physician judgment in cardiology: the art of medicine lives on. J Am Coll Cardiol 2006;48:954-955.
16. Sabaté M, Jiménez-Quevedo P, Angiolillo JD, Gómez-Hospital JA, Alfonso F, Hernández-Antolín R, Goicolea J, Bañuelos C, Escaned J, Moreno R, Fernández C, Fernándes-Avillés F, Macaya C, DIABETES Investigators. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: The diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation 2005; 112: 2175-2183.
17. Feit F, Brooks MM, Sopko G, Keller NM, Rosen A, Krone R, Berger PB, Shemin R, Attubato MJ, Williams DO, Frye R, Detre KM, for the BARI Investigator. Long-term clinical outcome in the Bypass Angioplasty Revascularization Registry. Circulation 2000;101:2795-2802.
18. Smith PK, Califf RM, Tuttle RH, Shaw LK, Lee KL, Delong ER, Lilly RE, Sketch MH Jr, Peterson ED, Jones RH. Selection of surgical or percutaneous coronaronary intervention provides differential longevity benefit. Ann Thorac Surg 2006;82:1420-1429.
19. Henderson RA, Pocock SJ, Clayton TC, Knight R, Fox KA, Julian DG, Chamberlain DA; Second Randomized Intervention Treatment of Angina (RITA-2) Trial Participants. Seven-year outcome in the RITA-2 trial: Coronary angioplasty versus medical therapy. J Am Coll Cardiol 2003;42:1161-1170.
20. van den Brand MJBM, Rensing BJ, Morel MA, Foley DP, de Valk V, Breeman A, Suryapranata H, Haalebos MMP, Wijns W, Wellens F, Balcon R, Magee P, Ribeiro E, Buffolo E, Unger F, Serruys PW. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol 2002;39:559-564.
21. Teirstein PS. The duelling hazards of incomplete revascularization and incomplete data. Circulation 2006;113:2380-2382.
22. Serruys PW, Ong ATL, Morice MC, et al. Arterial revascularization therapies, Part 2: sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. Eurointervention 2005;2:147-156.
23. Barsness GW, Gersh BJ, Brooks MM, Frye RL. BARI 2D Trial Investigators. Rationale for the revascularization arm of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Am J Cardiol 2006;97:31G-40G.
24. Hannan EL, Wu C, Walford G, Culliford AT, Gold JP, Smith CR, Higgins RS, Carlson RE, Jones RS. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 2008;358:331-341.
25. Rodriguez AE, Maree AO, Mieres J, Berrocal D, Grinfeld L, Fernandez-Pereira C, Curutto V, Rodriguez-Granillo A, O'Neill W, Palacios IF. Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 Years follow-up of the ERACI III registry. Eur Heart J 2007;28:2118-2125.